CIP
EVH icon

Convergence Investment Partners’s Evolent Health EVH Stock Holding History

Convergence Investment Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,053
Closed -$228K – 225
2022
Q1 		$228K Buy
+7,053
New +$185K 0.12% 168

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Convergence Investment Partners's EVH Position: Q2 2022 in Review

Convergence Investment Partners sold out of Evolent Health (EVH) in Q2 2022, closing a stake of 7,053 shares — an estimated $228K sold.

Convergence Investment Partners first reported a position in EVH in Q1 2022 and held it in 1 quarter. The position peaked at $228K in Q1 2022. 215 funds tracked by Wall St. Rank hold EVH as of Q2 2022.

  • Convergence Investment Partners reported no remaining Evolent Health position as of Q2 2022 after selling out during the quarter.
  • Convergence Investment Partners sold 7,053 Evolent Health shares in Q2 2022, an estimated $228K.
  • Convergence Investment Partners first reported a position in Evolent Health in Q1 2022 and held it in 1 quarter.
  • Convergence Investment Partners's Evolent Health position peaked at $228K in Q1 2022.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q2 2022.

Based on Convergence Investment Partners's 13F filing for Q2 2022, filed 5 Aug 2022.